SOURCE: Edwards Lifesciences

Edwards Lifesciences

May 30, 2012 12:01 ET

Edwards Lifesciences to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference

IRVINE, CA--(Marketwire - May 30, 2012) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Goldman Sachs 33rd Annual Global Healthcare Conference at Terranea in Rancho Palos Verdes, California on Wednesday, June 6, 2012.

Thomas M. Abate, Edwards Lifesciences' corporate vice president, chief financial officer, is scheduled to speak to conference attendees at 2:40 p.m. PDT. A live webcast of the discussion will be available to all interested parties on the Edwards Lifesciences investor relations website at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.

Contact Information

  • Media Contact:
    Amanda Fowler
    949-250-5070

    Investor Contact:
    David K. Erickson
    949-250-6826

    Edwards Lifesciences Corporation
    One Edwards Way
    Irvine, CA USA 92614
    Phone: 949.250.2500
    Fax: 949.250.2525
    www.edwards.com